Mushroom Microdosing: Moms Tout Benefits But Doctor’s Warn of Risks

Mushroom Microdosing: Moms Tout Benefits But Doctor's Warn of Risks

Mushroom Microdosing: Can It Help Mothers with Stress and Anxiety?

A Growing Trend in Psychedelic Therapy

Microdosing of “magic” mushrooms, or psilocybin, is a growing trend among mothers seeking relief from their daily stress and anxiety. According to some reports, thousands of women are taking small, sub-hallucinogenic doses of these psychedelic substances to improve their mental health.

On various social media platforms and online forums, groups like “Moms on Mushrooms” have been promoting anecdotal evidence of psilocybin’s benefits for mothers while also discussing the risks involved in this controversial treatment method. These groups have attracted tens of thousands of followers, indicating that there is much interest among parents and caregivers for natural remedies to common mental health issues.

The Science of Mushroom Microdosing

While scientific research on microdosing psychedelics like psilocybin is still in its infancy, there are indications that it may indeed offer some benefits for women seeking relief from depression, anxiety, and PTSD.

Peggy Van de Plassche, a former Canadian businesswoman turned founder of The Microdose Diet, claims that microdosing can help “rewire the brain, calm the body, master emotions and raise energy to reach more success” while addressing the complex psychological challenges of parenting, aging, and work. Van de Plassche, author of the book “MORE! The Microdose Diet – The 90-Day Plan for More Success, Passion, and Happiness,” has created a holistic program that includes alternative medicines such as psilocybin to help women achieve their goals.

Van de Plassche cites three potential benefits of microdosing mushrooms. Women report significant improvements in their emotional and mental health, including improved mood stability and emotional responsiveness. Microdosing may also help diminish symptoms of depression, anxiety, and PTSD. Finally, microdosing may enhance problem-solving capabilities and creativity.

Risks and Concerns About Mushroom Microdosing

Despite the anecdotal evidence and potential benefits of microdosing with psilocybin, there are also inherent risks and concerns. Medical professionals warn that there is not enough research and safety data available to validate the effectiveness of these alternative treatments.

As Dr. Adam D. Scioli, Chief Medical Officer of Caron Treatment Centers in Pennsylvania, warns, microdosing psychedelics can cause a psychotic or manic episode, especially in those with a personal or family history of schizophrenia or bipolar disorder. Other potential risks include paranoia and worsened depression or anxiety.

Until there is more conclusive research, Scioli advises that adults should avoid microdosing with mind-altering substances outside a clinical setting and under the supervision of a board-certified physician. He also cites the unknown potency and purity of the substances, which can be extremely dangerous if they interact with other medications or exacerbate underlying mental health issues.

Mushroom Microdosing and Women’s Mental Health

Despite these risks, Van de Plassche believes that microdosing has great potential to help women navigate the psychological and physiological symptoms of menopause, such as mood swings, insomnia, and fatigue. It can also help women “reclaim a sense of agency” over their minds and spirits.

As women continue to seek natural solutions to their mental health issues, the debate over the benefits and risks of mushroom microdosing will undoubtedly continue. However, it is crucial that women interested in these alternative treatments research thoroughly and speak with their doctors beforehand to discuss the benefits and potential risks for their specific health needs.

Originally Post From https://www.foxnews.com/health/moms-microdosing-mushrooms-touting-benefits-risks-exist-doctors

Read more about this topic at
Adults who microdose psychedelics report health related …
The popularity of microdosing of psychedelics: What does …

Glofitamab GemOx Outperforms Rituximab GemOx in Lymphoma

FDA Approves EPKINLY to Treat Patients with Follicular Lymphoma in The Weekly Journal